Testing a new skin medication for severe eczema in two stages

This trial is testing a new medication called DCY636 to see if it can safely treat moderate to severe atopic dermatitis (eczema). The study has two parts: first, researchers give increasing doses of the medication to healthy volunteers to check for side effects, and then they test it in people who actually have severe eczema. This helps doctors understand how the medication works in the body and whether it might help people whose eczema isn't controlled by creams and lotions alone.

Many people with severe eczema don't get enough relief from topical treatments like creams and ointments. This medication is being developed to offer a new treatment option for those whose condition remains moderate to severe despite current standard care.